Specificity of effector mechanisms in syngeneic graft-vs-host disease: recognition of the MHC class II invariant chain peptide (CLIP).
Hess
A
A
Johns Hopkins Bone Marrow Transplant Unit, Baltimore, Maryland, USA.
Thoburn
C
C
Bright
E
E
Horwitz
L
L
D019264:Adoptive Transfer; D000595:Amino Acid Sequence; D000818:Animals; D000944:Antigens, Differentiation, B-Lymphocyte / Q000032:analysis / Q000737:chemistry / Q000276:immunology*; D016026:Bone Marrow Transplantation / Q000276:immunology*; D002999:Clone Cells; D016572:Cyclosporine / Q000494:pharmacology; D005260:Female; D006086:Graft vs Host Disease / Q000276:immunology* / Q000473:pathology; D000949:Histocompatibility Antigens Class II / Q000032:analysis / Q000737:chemistry / Q000276:immunology*; D007165:Immunosuppression Therapy; D008212:Lymphocyte Depletion; D008969:Molecular Sequence Data; D051381:Rats; D011917:Rats, Inbred Lew; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000276:immunology; D013154:Spleen / Q000276:immunology / Q000473:pathology; D013601:T-Lymphocytes / Q000276:immunology; D013934:Thymectomy; D014185:Transplantation, Isogeneic / Q000276:immunology; D014916:Whole-Body Irradiation
D000944:Antigens, Differentiation, B-Lymphocyte; D000949:Histocompatibility Antigens Class II; D016693:Receptors, Antigen, T-Cell, alpha-beta; C045084:invariant chain; D016572:Cyclosporine